SD Biosensor, Inc. (KRX:137310)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,540.00
-250.00 (-3.68%)
Last updated: Aug 12, 2026, 2:52 PM KST

SD Biosensor Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-470,727-512,106-98,411-467,712911,3621,088,471
Depreciation & Amortization
130,464134,266141,694137,54140,82019,115
Loss (Gain) From Sale of Assets
-6,077-7,748-4,0921,0451,8041,373
Asset Writedown & Restructuring Costs
753,790753,790135,26299,8698,6342,283
Loss (Gain) From Sale of Investments
-6,887-530.9412,378-4,046-3,107-9,480
Loss (Gain) on Equity Investments
15,14115,1553,532986.912,560-2,802
Stock-Based Compensation
11,121803.15905.39969.115,55918,867
Provision & Write-off of Bad Debts
-2,023-923.756,9764,0579,6401,319
Other Operating Activities
-8,27122,884-24,055-33,212-31,661224,801
Change in Accounts Receivable
-23,871-29,3709,636-5,17762,516185,970
Change in Inventory
-15,974-10,303-5,89681,644-28,60435,418
Change in Accounts Payable
27,41619,6358,069-31,006-36,683-304,205
Change in Other Net Operating Assets
-34,018-28,037-29,472-27,277-63,831-26,185
Operating Cash Flow
370,083357,516156,527-242,319889,0081,234,945
Operating Cash Flow Growth
188.57%128.41%---28.01%149.29%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-54,636-57,086-78,783-142,566-301,999-190,053
Sale of Property, Plant & Equipment
86,49086,3819,5682,9622,915731.12
Cash Acquisitions
-7,922-8,066--1,748,595-47,154-36,764
Divestitures
--565.25---
Sale (Purchase) of Intangibles
-310.7-403.73-2,118-1,864-3,248-1,980
Investment in Securities
102,382-155,268-260,670-16,366706,574-901,853
Other Investing Activities
-26,049860.71-7,649-6,1002,658169,690
Investing Cash Flow
94,611-139,944-338,926-1,912,529359,745-960,569

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3,059--81,679-
Long-Term Debt Issued
-14,93313,640835,483--
Total Debt Issued
7,09817,99313,640835,48381,679-
Short-Term Debt Repaid
--1,940-133,468-255,617-81,695-1,765
Long-Term Debt Repaid
--8,042-8,041-13,822-11,623-4,968
Total Debt Repaid
-392,523-9,982-141,509-269,439-93,319-6,733
Net Debt Issued (Repaid)
-385,4258,011-127,869566,044-11,640-6,733
Issuance of Common Stock
-164.82-227,6042,383507,472
Repurchase of Common Stock
-0-11,575-18,425---99,644
Dividends Paid
-24,164-24,183-38.07-29,550-198,735-49,831
Other Financing Activities
-1,667067.35,664-17,7452,839
Financing Cash Flow
-411,256-27,582-146,266769,762-225,737354,102

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1,774-633.5623,705-5,476-31,6659,899
Net Cash Flow
55,213189,356-304,960-1,390,561991,351638,377

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
315,447300,43177,744-384,884587,0081,044,892
Free Cash Flow Growth
434.93%286.44%---43.82%137.22%
Free Cash Flow Margin
43.89%42.28%11.19%-58.70%20.02%35.66%
Free Cash Flow Per Share
2636.382510.42635.94-3471.825794.8110714.52
Levered Free Cash Flow
-27,452-44,627-93,587-250,134402,401766,104
Unlevered Free Cash Flow
36,06223,014-50,719-219,366403,022766,410

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
25,30925,68431,85559,592984.72497.84
Cash Income Tax Paid
--338,038-84,493198,926537,064132,849
Change in Working Capital
-46,448-48,074-17,66218,183-66,603-109,001